research people publication/patent laboratory community gallery sitelink contact us
상단이미지
people

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
 
publication
 
번호 구분 학술지명 논문명 Impact
Factor		 게재년월
236 SCI ACS Nano Smart Accumulating Dual-Targeting Lipid Envelopes Equipping Oncolytic Adenovirus for Enhancing Cancer Gene Therapeutic Efficacy 15.8 2024.10
235 SCI Molecular therapy CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in a mouse model of lung cancer 12.1 2024.10
234 SCI International jounal of molecular sciences Ethyl Pyruvate Decreases Collagen Synthesis and Upregulates MMP Activity in Keloid Fibroblasts and Keloid Spheroids 4.9 2024.05
233 SCI Frontiers in immunology Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy 7.3 2024.05
232 SCI Frontiers in immunology Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer 7.3 2024.05
231 SCI The Jounal of biological chemistry Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression 4.0 2024.04
230 SCI Cell death disease Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis 9.696 2024. 01
229 SCI Advanced Science (Weinh) A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality 17.521 2023.11
228 SCI Cancer Letter Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here? 9.7 2023.10
227 SCI ACS Biomater Sci Eng. Enhanced Immunogenic Cell Death by Apoptosis/Ferroptosis Hybrid Pathway Potentiates PD-L1 Blockade Cancer Immunotherapy 5.13 2022.11
226 SCI Cancer Gene Ther Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses 5.987 2022.10
225 SCI Frontiers in Immunology Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements 8.786 2022.08
224 SCI Int J Mol Sci Effect of Mortalin on Scar Formation in Human Dermal Fibroblasts and a Rat Incisional Scar Model 6.01 2022.07
223 SCI Front Cell Dev Biol Why is Mortalin a Potential Therapeutic Target for Cancer? 5.69 2022.06
222 SCI Biomater Sci Bioreducible polymer-mediated delivery of oncolytic adenovirus can attenuate antiviral immune response and concurrently enhance the induction of antitumor immune response to effectively prevent metastasis 6.843 2022.06
221 SCI International Journal of Molecular Sciences ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells 5.542 2022.06
220 SCI Cancer Gene Ther Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses 5.987 2022.04
219 SCI Mol Ther Oncolytics Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors 7.2 2022.03
218 SCI Pharmaceutics A pH-and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery 6.072 2022.03
217 SCI Front Immunol Polymeric Systems for Cancer Immunotherapy: A Review 7.561 2022.02

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | [다음 10페이지]